Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease

Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the... ORIGINAL INVESTIGATION Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease Maura Paul-Labrador, MPH; Donna Polk, MD, MPH; James H. Dwyer, PhD†; Ivan Velasquez, MD; Sanford Nidich, PhD; Maxwell Rainforth, PhD; Robert Schneider, MD; C. Noel Bairey Merz, MD Background: The metabolic syndrome is thought to be reactivity testing; and cardiac autonomic system activ- a contributor to coronary heart disease (CHD), and com- ity measured by heart rate variability. ponents of the syndrome have been identified as pos- Results: The TM group had beneficial changes (measured sible therapeutic targets. Previous data implicate neuro- as mean ± SD) in adjusted systolic blood pressure (−3.4 ± 2.0 humoral activation related to psychosocial stress as a contributor to the metabolic syndrome. The aim of this vs 2.8 ± 2.1 mm Hg;P = .04), insulin resistance (−0.75 ± 2.04 study was to evaluate the efficacy of transcendental medi- vs 0.52 ± 2.84;P = .01), and heart rate variability (0.10 ± 0.17 tation (TM) on components of the metabolic syndrome vs −0.50 ± 0.17 high-frequency power; P = .07) compared and CHD. with the health education group, respectively. There was no effect http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease

Loading next page...
 
/lp/american-medical-association/effects-of-a-randomized-controlled-trial-of-transcendental-meditation-gXNEr0404y
Publisher
American Medical Association
Copyright
Copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinte.166.11.1218
pmid
16772250
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease Maura Paul-Labrador, MPH; Donna Polk, MD, MPH; James H. Dwyer, PhD†; Ivan Velasquez, MD; Sanford Nidich, PhD; Maxwell Rainforth, PhD; Robert Schneider, MD; C. Noel Bairey Merz, MD Background: The metabolic syndrome is thought to be reactivity testing; and cardiac autonomic system activ- a contributor to coronary heart disease (CHD), and com- ity measured by heart rate variability. ponents of the syndrome have been identified as pos- Results: The TM group had beneficial changes (measured sible therapeutic targets. Previous data implicate neuro- as mean ± SD) in adjusted systolic blood pressure (−3.4 ± 2.0 humoral activation related to psychosocial stress as a contributor to the metabolic syndrome. The aim of this vs 2.8 ± 2.1 mm Hg;P = .04), insulin resistance (−0.75 ± 2.04 study was to evaluate the efficacy of transcendental medi- vs 0.52 ± 2.84;P = .01), and heart rate variability (0.10 ± 0.17 tation (TM) on components of the metabolic syndrome vs −0.50 ± 0.17 high-frequency power; P = .07) compared and CHD. with the health education group, respectively. There was no effect

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jun 12, 2006

References